| Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis PJ Teoh, O An, TH Chung, JY Chooi, SHM Toh, S Fan, W Wang, BTH Koh, ... Blood, The Journal of the American Society of Hematology 132 (12), 1304-1317, 2018 | 94 | 2018 |
| Immunotherapy in Multiple Myeloma CY Soekojo, M Ooi, S de Mel, WJ Chng Cells 9 (3), 601, 2020 | 38 | 2020 |
| Stem-cell transplantation in multiple myeloma: how far have we come? CY Soekojo, SK Kumar Therapeutic Advances in Hematology 10, 2040620719888111, 2019 | 26 | 2019 |
| Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network CY Soekojo, K Kim, SY Huang, CS Chim, N Takezako, H Asaoku, ... Blood cancer journal 9 (10), 1-10, 2019 | 17 | 2019 |
| Epicardial and visceral adipose tissue in relation to subclinical atherosclerosis in a Chinese population N Ei Ei Khaing, TE Shyong, J Lee, CY Soekojo, A Ng, RM Van Dam PloS one 13 (4), e0196328, 2018 | 15 | 2018 |
| Potential clinical application of genomics in multiple myeloma CY Soekojo, S De Mel, M Ooi, B Yan, WJ Chng International journal of molecular sciences 19 (6), 1721, 2018 | 11 | 2018 |
| Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis CY Soekojo, G Wang, Y Chen, J Casan, G Wolyncewicz, A Lin, LM Poon, ... Clinical Lymphoma Myeloma and Leukemia 19 (8), e470-e477, 2019 | 8 | 2019 |
| Education‐based interventions to minimize sampling errors in transfusion S de Mel, S Lim, CY Soekojo, C Thow, SP Lang, SY Lee, LK Tan ISBT Science Series 12 (2), 307-313, 2017 | 5 | 2017 |
| Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer Center CY Soekojo, JZ Low, J Oh, M Ooi, S De Mel, WJ Chng Clinical Lymphoma Myeloma and Leukemia, 2020 | 4 | 2020 |
| Salsalate is An Active Agent in Multiple Myeloma CY Soekojo, S de Mel, MIB Azaman, NB Mustafa, WJ Chng Clinical Lymphoma, Myeloma and Leukemia 19 (10), e135, 2019 | | 2019 |
| Surgical Management of Multiple Myeloma with Symptomatic Involvement of the Spine H Milavec, N Ravikumar, NL Syn, CY Soekojo, CJ Wee, N Kumar SWISS MEDICAL WEEKLY 149, 49S-49S, 2019 | | 2019 |
| ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS P Teoh, O An, T Chung, J Chooi, S Toh, S Fan, W Wang, B Koh, ... Hematological Oncology 37, 549-549, 2019 | | 2019 |
| Evaluation of Maintenance Therapy in Myeloma in an Asian Population CY Soekojo, S De Mel, M Ooi, WJ Chng Blood 132 (Supplement 1), 3231-3231, 2018 | | 2018 |
| Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging CY Soekojo, G Wang, Y Chen, J Casan, G Wolyncewicz, A Lin, LM Poon, ... Blood 130 (Supplement 1), 3119-3119, 2017 | | 2017 |
| Cytogenetic Abnormalities and Treatment with New Drugs on Clinical Trials Are Important Prognostic Markers for Myeloma in the Era of ISS and FISH Analysis CY Soekojo, A Lin, M Poon, LP Koh, LK Tan, MG Ooi, WJ Chng Blood, The Journal of the American Society of Hematology 128 (22), 4498-4498, 2016 | | 2016 |
